Joshua Pasanisi Health Care: Biotechnology 2007 In the top spot for a third straight year is Mark Schoenebaum, the Bear Stearns analyst whose work is described by one buy-sider as “unique and refreshing.” Joshua Pasanisi October 15, 2007